TRIM33 and cancer: In addition, anti-TIF1γ-positive DM patients developed cancers closer to the time of the diagnosis of DMM than anti-TIF1γ-negative DM patients [163].These results suggest anti-TIF-γ auto-antibodies as a potential tumor auto-antigen and should alert the doctor to the possibility of underlying cancer.